» Articles » PMID: 39968281

Donor Modulation Brings All-in-one Phototheranostics for NIR-II Imaging-guided Type-I Photodynamic/photothermal Synergistic Cancer Therapy

Overview
Journal Chem Sci
Specialty Chemistry
Date 2025 Feb 19
PMID 39968281
Authors
Affiliations
Soon will be listed here.
Abstract

Type-I photodynamic (PDT) and photothermal (PTT) synergistic therapy guided by fluorescence imaging in the near-infrared region II (NIR-II) is crucial for cancer diagnosis and treatment. Phototheranostics provide a promising system for efficient imaging-guided phototherapy, combining diagnostics with therapeutics within a single photosensitizer and avoiding the complexity of composition and low reproducibility of combination methods. Herein, we design and synthesize an all-in-one phototheranostic agent OTAB by modifying aza-BODIPY with a methoxy group substituted triphenylamine moiety, followed by the formation of nanoparticle OTAB@cRGD NPs self-assembly with DSPE-PEG-cRGD. Structurally, the methoxy-modified triphenylamine moiety as a strong electron donor can reduce the singlet-triplet energy gap (Δ ) by creating a strong intramolecular charge transfer state, thereby accelerating the intersystem crossing process and thus preferentially generating O˙ electron transfer. A single 808 nm laser can trigger its NIR-II imaging and excellent type-I photodynamic and photothermal therapy. Furthermore, OTAB@cRGD NPs with high photostability, colloid stability and biocompatibility can actively target tumor tissue intravenous injection. Thus, tumor localization and imaging diagnosis are successfully realized. The PDT/PTT synergistic therapy brings efficient tumor inhibition and ablation both and . Therefore, this work provides a new strategy to construct an all-in-one multifunctional probe for the integration of NIR-II diagnosis and treatment.

References
1.
Zhang W, Kang M, Li X, Yang H, Zhang Z, Li Z . Interstitial Optical Fiber-Mediated Multimodal Phototheranostics Based on an Aggregation-Induced NIR-II Emission Luminogen for Orthotopic Breast Cancer Treatment. Adv Mater. 2024; 36(38):e2406474. DOI: 10.1002/adma.202406474. View

2.
Wang Y, Li Y, Zhang Z, Wang L, Wang D, Tang B . Triple-Jump Photodynamic Theranostics: MnO Combined Upconversion Nanoplatforms Involving a Type-I Photosensitizer with Aggregation-Induced Emission Characteristics for Potent Cancer Treatment. Adv Mater. 2021; 33(41):e2103748. DOI: 10.1002/adma.202103748. View

3.
Zhang Z, Zhou Y, Zhao S, Ding L, Chen B, Chen Y . Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy. Adv Sci (Weinh). 2022; 9(35):e2203583. PMC: 9762308. DOI: 10.1002/advs.202203583. View

4.
Li S, Gu K, Wang H, Xu B, Li H, Shi X . Degradable Holey Palladium Nanosheets with Highly Active 1D Nanoholes for Synergetic Phototherapy of Hypoxic Tumors. J Am Chem Soc. 2020; 142(12):5649-5656. DOI: 10.1021/jacs.9b12929. View

5.
Zhu M, Zhang H, Ran G, Mangel D, Yao Y, Zhang R . Metal Modulation: An Easy-to-Implement Tactic for Tuning Lanthanide Phototheranostics. J Am Chem Soc. 2021; 143(19):7541-7552. DOI: 10.1021/jacs.1c03041. View